PODD vs TPCS · P/E 34, rev $2.07B vs rev $34.0M
Insulet Corporation (PODD) versus TechPrecision Corporation Common stock (TPCS) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
TechPrecision Corporation Common stock (TPCS) is a metal fabrication company listed on NASDAQ.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported TPCS revenue for 2025-03-31 was $34.0M. Net income was -$2.7M. Revenue was up 7.7% from 2024-03-31 to 2025-03-31. TPCS currently screens at market cap $34.5M.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. TPCS currently screens at market cap $34.5M.
Not investment advice. Open the PODD and TPCS stock pages for the full models.
Not investment advice.